ID

32496

Descrizione

Study ID: 106837 Clinical Study ID: HZA106837 Study Title: A Long-Term, Randomized, Double-Blind, Parallel Group Study of Fluticasone Furoate/GW642444 Inhalation Powder Once-Daily and Fluticasone Furoate Inhalation Powder Once-Daily in Subjects with Asthma Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01086384 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fluticasone furoate/vilanterol Trade Name: Relvar Study Indication: Asthma

Keywords

versioni (4)

1. 05/11/18 05/11/18 -
2. 05/11/18 05/11/18 -
3. 04/12/18 04/12/18 -
4. 30/10/19 30/10/19 - Sarah Riepenhausen

Titolare del copyright

GSK group of companies

Caricato su

5 novembre 2018

DOI

Per favore, per richiedere un accesso.

Licenza